HIV Envelope Protein gp160
"HIV Envelope Protein gp160" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An envelope protein of the human immunodeficiency virus that is encoded by the HIV env gene. It has a molecular weight of 160,000 kDa and contains numerous glycosylation sites. It serves as a precursor for both the HIV ENVELOPE PROTEIN GP120 and the HIV ENVELOPE PROTEIN GP41.
| Descriptor ID |
D019302
|
| MeSH Number(s) |
D12.776.964.775.325.164.374 D12.776.964.775.562.500.750 D12.776.964.970.880.325.164.374
|
| Concept/Terms |
HIV Envelope Protein gp160- HIV Envelope Protein gp160
- Envelope Glycoprotein gp160, HIV
- HTLV-III gp160
- HTLV III gp160
- gp160, HTLV-III
- gp160(HIV)
- HIV Envelope Glycoprotein gp160
- env Protein gp160, HIV
- gp160 Envelope Glycoprotein, HIV
|
Below are MeSH descriptors whose meaning is more general than "HIV Envelope Protein gp160".
Below are MeSH descriptors whose meaning is more specific than "HIV Envelope Protein gp160".
This graph shows the total number of publications written about "HIV Envelope Protein gp160" by people in this website by year, and whether "HIV Envelope Protein gp160" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2011 | 1 | 1 | 2 |
| 2017 | 5 | 0 | 5 |
| 2018 | 0 | 3 | 3 |
| 2019 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "HIV Envelope Protein gp160" by people in Profiles.
-
Prediction of VRC01 neutralization sensitivity by HIV-1 gp160 sequence features. PLoS Comput Biol. 2019 04; 15(4):e1006952.
-
Combination therapy with anti-HIV-1 antibodies maintains viral suppression. Nature. 2018 09; 561(7724):479-484.
-
HIV-1 latent reservoir size and diversity are stable following brief treatment interruption. J Clin Invest. 2018 07 02; 128(7):3102-3115.
-
Interdomain Stabilization Impairs CD4 Binding and Improves Immunogenicity of the HIV-1 Envelope Trimer. Cell Host Microbe. 2018 06 13; 23(6):832-844.e6.
-
High-Throughput Protein Engineering Improves the Antigenicity and Stability of Soluble HIV-1 Envelope Glycoprotein SOSIP Trimers. J Virol. 2017 11 15; 91(22).
-
HLA-B*14:02-Restricted Env-Specific CD8+ T-Cell Activity Has Highly Potent Antiviral Efficacy Associated with Immune Control of HIV Infection. J Virol. 2017 11 15; 91(22).
-
Design and crystal structure of a native-like HIV-1 envelope trimer that engages multiple broadly neutralizing antibody precursors in vivo. J Exp Med. 2017 Sep 04; 214(9):2573-2590.
-
Structure and topology around the cleavage site regulate post-translational cleavage of the HIV-1 gp160 signal peptide. Elife. 2017 07 28; 6.
-
Antigenicity-defined conformations of an extremely neutralization-resistant HIV-1 envelope spike. Proc Natl Acad Sci U S A. 2017 04 25; 114(17):4477-4482.
-
Prime-boost vaccination with heterologous live vectors encoding SIV gag and multimeric HIV-1 gp160 protein: efficacy against repeated mucosal R5 clade C SHIV challenges. Vaccine. 2011 Aug 05; 29(34):5611-22.